Maria Emília Rabelo Andrade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Emília Rabelo Andrade has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Valbert Nascimento Cardoso
Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
4 shared publications - Amanda Dias Borges
Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
3 shared publications - Jacqueline Isaura Alvarez Leite
Universidade Federal de Minas Gerais
2 shared publications - Luiz Octávio Pires
Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
2 shared publications - Luísa Martins Trindade
Nursing School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
2 shared publications - Paola Caroline Lacerda Leocádio
Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais , Belo Horizonte, Minas Gerais 31270-901
2 shared publications
Latest Publications
- Open Access
- 6 November 2025
- Published by Elsevier in Clinical Nutrition Open Science
- Vol. 64, 377-390
Vitamin C and L-arginine as potential synergistic adjuvants to recover intestinal mucositis induced by chemotherapy
- 6 November 2025
- Published by Elsevier in Clinical Nutrition Open Science
- Vol. 64, 377-390
Open AccessVitamin C and L-arginine as potential synergistic adjuvants to recover intestinal mucositis induced by chemotherapy
- 4 November 2024
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 77 (11)
Mitigation of chemotherapy-induced experimental intestinal mucositis through postbiotic lactate
Postbiotic lactate modulates the immune system in inflammatory bowel diseases. However, its role in experimental intestinal mucositis (IM) has not been elucidated. This study aimed to evaluate the effects of lactate supplementation (1 and 2 × 10−1 mol/L) in a 5-fluorouracil (5-FU)-induced IM model. Male BALB/c mice (6–8 weeks old) were randomly divided into four groups: control (CTL), mucositis (MUC), mucositis with 1 × 10−1 mol/L lactate solution (MUC10), and mucositis with 2 × 10−1 mol/L lactate solution (MUC200). Lactate was administered via oral gavage for 10 days. Following the treatment period, the animals were subjected to an intraperitoneal injection of 300 mg/kg 5-FU to induce IM and were euthanized 72 h later for analysis. The MUC group presented intestinal damage with a poor histological score and decreased morphometric parameters as well as decreased mucus production and increased inflammatory infiltration and intestinal permeability compared to those of the CTL group (p < 0.05). However, the MUC200 group exhibited better results for the evaluated parameters than the MUC group (p < 0.05). Notably, the results in the MUC10 group were similar to those in the MUC group (p > 0.05). In conclusion, lactate supplementation attenuates mucositis-induced damage in a dose-dependent manner.
- 4 November 2024
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 77 (11)
Mitigation of chemotherapy-induced experimental intestinal mucositis through postbiotic lactate
Postbiotic lactate modulates the immune system in inflammatory bowel diseases. However, its role in experimental intestinal mucositis (IM) has not been elucidated. This study aimed to evaluate the effects of lactate supplementation (1 and 2 × 10−1 mol/L) in a 5-fluorouracil (5-FU)-induced IM model. Male BALB/c mice (6–8 weeks old) were randomly divided into four groups: control (CTL), mucositis (MUC), mucositis with 1 × 10−1 mol/L lactate solution (MUC10), and mucositis with 2 × 10−1 mol/L lactate solution (MUC200). Lactate was administered via oral gavage for 10 days. Following the treatment period, the animals were subjected to an intraperitoneal injection of 300 mg/kg 5-FU to induce IM and were euthanized 72 h later for analysis. The MUC group presented intestinal damage with a poor histological score and decreased morphometric parameters as well as decreased mucus production and increased inflammatory infiltration and intestinal permeability compared to those of the CTL group (p < 0.05). However, the MUC200 group exhibited better results for the evaluated parameters than the MUC group (p < 0.05). Notably, the results in the MUC10 group were similar to those in the MUC group (p > 0.05). In conclusion, lactate supplementation attenuates mucositis-induced damage in a dose-dependent manner.
- 1 November 2021
- Published by Elsevier in Experimental Parasitology
- Vol. 230, 108158
Effect of dexamethasone on experimental enteritis produced by Giardia lamblia in a Meriones unguiculatus model
- 1 November 2021
- Published by Elsevier in Experimental Parasitology
- Vol. 230, 108158
Effect of dexamethasone on experimental enteritis produced by Giardia lamblia in a Meriones unguiculatus model